SI2691412T1 - Makrociklična spojina in postopki za njeno izdelavo - Google Patents

Makrociklična spojina in postopki za njeno izdelavo

Info

Publication number
SI2691412T1
SI2691412T1 SI201230145T SI201230145T SI2691412T1 SI 2691412 T1 SI2691412 T1 SI 2691412T1 SI 201230145 T SI201230145 T SI 201230145T SI 201230145 T SI201230145 T SI 201230145T SI 2691412 T1 SI2691412 T1 SI 2691412T1
Authority
SI
Slovenia
Prior art keywords
production
methods
macrocyclic compound
macrocyclic
compound
Prior art date
Application number
SI201230145T
Other languages
English (en)
Inventor
Steven James Moss
Matthew Alan Gregory
Barrie Wilkinson
Original Assignee
Neurovive Pharmaceutical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1105293.3A external-priority patent/GB201105293D0/en
Priority claimed from GBGB1113629.8A external-priority patent/GB201113629D0/en
Priority claimed from GBGB1202060.8A external-priority patent/GB201202060D0/en
Application filed by Neurovive Pharmaceutical Ab filed Critical Neurovive Pharmaceutical Ab
Publication of SI2691412T1 publication Critical patent/SI2691412T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355Non-condensed oxazines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
SI201230145T 2011-03-29 2012-03-29 Makrociklična spojina in postopki za njeno izdelavo SI2691412T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1105293.3A GB201105293D0 (en) 2011-03-29 2011-03-29 Novel compounds and methods for their production
GBGB1113629.8A GB201113629D0 (en) 2011-08-08 2011-08-08 Novel compounds and methods for their production
GBGB1202060.8A GB201202060D0 (en) 2012-02-07 2012-02-07 Novel compounds and methods for their production
EP12716538.9A EP2691412B1 (en) 2011-03-29 2012-03-29 Macrocyclic compound and methods for its production
PCT/GB2012/050700 WO2012131371A1 (en) 2011-03-29 2012-03-29 Macrocyclic compound and methods for its production

Publications (1)

Publication Number Publication Date
SI2691412T1 true SI2691412T1 (sl) 2015-05-29

Family

ID=46001313

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201230146T SI2691413T1 (sl) 2011-03-29 2012-03-29 Makrociklične spojine in postopki za njihovo izdelavo
SI201230145T SI2691412T1 (sl) 2011-03-29 2012-03-29 Makrociklična spojina in postopki za njeno izdelavo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI201230146T SI2691413T1 (sl) 2011-03-29 2012-03-29 Makrociklične spojine in postopki za njihovo izdelavo

Country Status (29)

Country Link
US (2) US9090657B2 (sl)
EP (2) EP2691413B1 (sl)
JP (2) JP6118793B2 (sl)
KR (2) KR101911484B1 (sl)
CN (3) CN103619869B (sl)
AR (1) AR085724A1 (sl)
AU (2) AU2012235880B2 (sl)
BR (2) BR112013024974A2 (sl)
CA (2) CA2830831C (sl)
CL (2) CL2013002739A1 (sl)
CY (2) CY1116318T1 (sl)
DK (2) DK2691412T3 (sl)
EA (2) EA023848B1 (sl)
ES (2) ES2533437T3 (sl)
HK (2) HK1189236A1 (sl)
HR (2) HRP20150184T1 (sl)
IL (2) IL228509B (sl)
JO (1) JO3063B1 (sl)
MX (2) MX345351B (sl)
MY (2) MY170637A (sl)
PL (2) PL2691413T3 (sl)
PT (2) PT2691412E (sl)
RS (2) RS53964B1 (sl)
SG (2) SG193568A1 (sl)
SI (2) SI2691413T1 (sl)
TW (1) TWI525098B (sl)
UY (1) UY33993A (sl)
WO (2) WO2012131371A1 (sl)
ZA (2) ZA201307149B (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012019866A8 (pt) 2010-02-09 2017-12-26 Biotica Tech Limited Composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto
JO3063B1 (ar) * 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab مركب مبتكر وطرق لانتاجه
CN103130734A (zh) * 2011-12-01 2013-06-05 上海药明康德新药开发有限公司 一种合成1,2-吗啉盐酸盐的方法
CN105695541B (zh) * 2016-03-10 2019-03-15 苏州华赛生物工程技术有限公司 一种抗生素nvp018中间体的分离纯化方法
KR20180036522A (ko) * 2016-09-30 2018-04-09 (주)나노믹스 스틸벤 유도체 및 그 제조 방법
BR112019009903A2 (pt) 2016-11-18 2019-08-13 Neurovive Pharmaceutical Ab análogo de sangliferina, combinação, composição farmacêutica, e, método para tratamento de um sujeito sofrendo de câncer ou de malignidade de célula-b
CN112410353B (zh) * 2019-08-23 2023-01-24 上海医药工业研究院 一种fkbS基因、含其的基因工程菌及其制备方法和用途
CN115028681B (zh) * 2022-08-11 2022-11-15 中国科学院微生物研究所 一种降解亲环素a的嵌合体化合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR006514A1 (es) 1995-07-04 1999-09-08 Sandoz Ag Un macrolido, sus usos, un proceso para producirlo, un aislado biologicamente puro capaz de producirlo, y una composicion farmaceutica quelo comprende
US6124453A (en) 1995-07-04 2000-09-26 Novartis Ag Macrolides
JP2008546708A (ja) * 2005-06-17 2008-12-25 ノバルティス アクチエンゲゼルシャフト Hcvにおけるサングリフェリンの使用
WO2008084368A2 (en) 2007-01-04 2008-07-17 Debiopharm Sa Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy
ES2556211T3 (es) 2008-09-24 2016-01-14 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences Agrupación de genes novedosa
CN101691575B (zh) * 2008-09-24 2013-06-05 中国科学院上海有机化学研究所 一种萨菲菌素的生物合成基因簇
WO2011098808A1 (en) * 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
WO2011098805A1 (en) * 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
BR112012019866A8 (pt) * 2010-02-09 2017-12-26 Biotica Tech Limited Composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto
JP6086869B2 (ja) * 2010-12-20 2017-03-08 ネウロビベ プハルマセウトイカル エービー サングリフェリン誘導体及びそれらの製造方法
JO3063B1 (ar) * 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab مركب مبتكر وطرق لانتاجه

Also Published As

Publication number Publication date
PL2691413T3 (pl) 2015-05-29
BR112013024965A2 (pt) 2017-04-18
US9139613B2 (en) 2015-09-22
AR085724A1 (es) 2013-10-23
IL228509A0 (en) 2013-12-31
CN103635484A (zh) 2014-03-12
AU2012235961B2 (en) 2016-09-01
CY1116186T1 (el) 2017-02-08
CN103635484B (zh) 2017-05-10
KR20140057481A (ko) 2014-05-13
MY170618A (en) 2019-08-21
PT2691412E (pt) 2015-03-25
JO3063B1 (ar) 2017-03-15
WO2012131371A1 (en) 2012-10-04
EA023907B1 (ru) 2016-07-29
EA201391399A1 (ru) 2014-02-28
CA2830827C (en) 2020-03-10
MX345352B (es) 2017-01-26
IL228509B (en) 2018-02-28
SG193568A1 (en) 2013-11-29
AU2012235880B2 (en) 2016-11-17
DK2691412T3 (en) 2015-04-07
ES2533437T3 (es) 2015-04-10
TW201300398A (zh) 2013-01-01
KR20140071958A (ko) 2014-06-12
AU2012235880A1 (en) 2013-10-17
HK1189237A1 (en) 2014-05-30
BR112013024974A2 (pt) 2016-09-06
IL228508A0 (en) 2013-12-31
KR101868084B1 (ko) 2018-06-18
EP2691413A1 (en) 2014-02-05
EP2691412B1 (en) 2014-12-24
AU2012235961A1 (en) 2013-10-10
UY33993A (es) 2012-10-31
CL2013002739A1 (es) 2014-07-11
PT2691413E (pt) 2015-03-25
CN103619869A (zh) 2014-03-05
CN103619869B (zh) 2015-11-25
HRP20150187T1 (en) 2015-06-05
CA2830827A1 (en) 2012-10-04
MX2013011043A (es) 2014-04-25
CN107417766A (zh) 2017-12-01
US9090657B2 (en) 2015-07-28
CY1116318T1 (el) 2017-02-08
RS53963B1 (en) 2015-08-31
JP2014514290A (ja) 2014-06-19
MX2013011051A (es) 2014-03-13
PL2691412T3 (pl) 2015-08-31
JP2014510746A (ja) 2014-05-01
EP2691413B1 (en) 2014-12-24
MX345351B (es) 2017-01-26
TWI525098B (zh) 2016-03-11
US20140038885A1 (en) 2014-02-06
JP6118792B2 (ja) 2017-04-26
CA2830831A1 (en) 2012-10-04
HK1189236A1 (en) 2014-05-30
ZA201307149B (en) 2015-04-29
US20120251581A1 (en) 2012-10-04
RS53964B1 (en) 2015-08-31
SG193569A1 (en) 2013-11-29
JP6118793B2 (ja) 2017-04-26
ES2533438T3 (es) 2015-04-10
CA2830831C (en) 2020-03-10
HRP20150184T1 (hr) 2015-05-08
ZA201307231B (en) 2015-05-27
EA201391396A1 (ru) 2014-02-28
CL2013002740A1 (es) 2014-07-11
IL228508B (en) 2018-01-31
MY170637A (en) 2019-08-21
DK2691413T3 (en) 2015-04-07
SI2691413T1 (sl) 2015-05-29
WO2012131377A1 (en) 2012-10-04
EA023848B1 (ru) 2016-07-29
KR101911484B1 (ko) 2018-10-24
EP2691412A1 (en) 2014-02-05

Similar Documents

Publication Publication Date Title
EP2736330A4 (en) COMPOUNDS AND METHODS
EP2747560A4 (en) CONNECTIONS AND METHODS
EP2736332A4 (en) CONNECTIONS AND METHODS
EP2722540A4 (en) STABILIZATION COMPOUND AND METHOD OF MANUFACTURING THEREOF
EP2736329A4 (en) COMPOUNDS AND METHODS
HK1189236A1 (en) Macrocyclic compound and methods for its production
EP2716970A4 (en) WASTE MELTING PROCESS
EP2657223A4 (en) METAL-SALEN COMPLEX COMPOUND AND PROCESS FOR PRODUCING THE SAME
EP2722159A4 (en) STRUCTURE AND MANUFACTURING METHOD THEREFOR
EP2754508A4 (en) METHOD FOR PRODUCING A SEAMLESS METAL TUBE
GB201105436D0 (en) Method
GB201101219D0 (en) Method
PT2581411E (pt) Composição de material sintético e processos para o seu fabrico
GB201121301D0 (en) Method
EP2752416A4 (en) NOVEL MANGROMICIN COMPOUND AND PROCESS FOR PRODUCING THE SAME
EP2752253A4 (en) METHOD FOR PRODUCING A SEAMLESS METAL TUBE
EP2940011A4 (en) PREPARATION FOR HALOHYDRANTOINE COMPOUND AND HALOHYDRANTOINE COMPOUND
EP2772544A4 (en) NEW CONNECTION AND METHOD FOR THE PRODUCTION THEREOF
GB201106283D0 (en) Method
GB201113629D0 (en) Novel compounds and methods for their production
GB201113626D0 (en) Novel compounds and methods for their production
GB201105293D0 (en) Novel compounds and methods for their production
GB201120225D0 (en) Precursor compounds and methods for making same
GB201021522D0 (en) Novel compounds and methods for their production
GB201121535D0 (en) Manufacturing method